Comparison between Indian Bank IPO and SMS Pharmaceuticals IPO.
Indian Bank IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while SMS Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Indian Bank IPO is up to ₹782.15 Cr whereas the issue size of the SMS Pharmaceuticals IPO is up to ₹98.01 Cr. The final issue price of Indian Bank IPO is ₹91.00 per share and of SMS Pharmaceuticals IPO is ₹380.00 per share.
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹77.00 per share | ₹360.00 per share |
| Issue Price (Upper) | ₹91.00 per share | ₹380.00 per share |
| Issue Price (Final) | ₹91.00 per share | ₹380.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 75 shares | 15 shares |
| Fresh Issue Size | 8,59,50,000 shares | 25,79,225 shares |
| Fresh Issue Size (Amount) | up to ₹782.15 Cr | up to ₹98.01 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 8,59,50,000 shares | 25,79,225 shares |
| Issue Size Total (Amount) | up to ₹782.15 Cr | up to ₹98.01 Cr |
Indian Bank IPO opens on Feb 05, 2007, while SMS Pharmaceuticals IPO opens on Feb 05, 2007. The closing date of Indian Bank IPO and SMS Pharmaceuticals IPO is Feb 09, 2007, and Feb 08, 2007, respectively.
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 05, 2007 | Feb 05, 2007 |
| Issue Close | Feb 09, 2007 | Feb 08, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Mar 01, 2007 | Feb 28, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Indian Bank IPO P/E ratio is , as compared to SMS Pharmaceuticals IPO P/E ratio of .
| Indian Bank IPO | SMS Pharmaceuticals IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 72.31 | ||||
| Promoter Shareholding (Post-Issue) | 80 | 53.68 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹3910.91 Cr. | ₹380.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 23.52 | 17.41 |
In the Indian Bank IPO Retail Individual Investors (RII) are offered 2,32,06,500 shares while in SMS Pharmaceuticals IPO retail investors are offered 2,32,06,500 shares. Qualified Institutional Buyers (QIB) are offered 4,64,13,000 shares in Indian Bank IPO and 12,88,500 shares in SMS Pharmaceuticals IPO.
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 4,64,13,000 shares | 12,88,500 shares |
| NII | 77,35,500 shares | 3,86,550 shares |
| RII | 2,32,06,500 shares | 9,01,950 shares |
| Employee | 85,95,000 shares | |
| Others | ||
| Total | 8,59,50,000 shares | 25,77,000 shares |
Indian Bank IPO subscribed 32.16x in total, whereas SMS Pharmaceuticals IPO subscribed 2.64x.
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 56.45x | 3.47x |
| NII (times) | 8.36x | 0.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.18x | 2.47x |
| Employee (times) | 0.63x | |
| Other (times) | ||
| Total (times) | 32.16x | 2.64x |
